Atropine Sulfate Injection Solution — Class I drug recall D-1153-2016
Terminated recall by Cantrell Drug Company, reported 2016-07-13, distributed nationwide. Subpotent Drug
| Recall number | D-1153-2016 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cantrell Drug Company, Little Rock, AR, United States |
| Recall initiated | 2015-08-21 |
| Classified | 2016-07-06 |
| Reported by FDA | 2016-07-13 |
| Terminated | 2017-02-03 |
| Distributed | Nationwide (US) |
| Reason classes | potency |
| NDC | 52533-0010-45 |
| Lot numbers | 149198, 149690, 151454, 151665, 151668, 151962 |
| Expiration dates | 2015-09-03, 2015-09-14, 2015-11-05, 2015-11-11 |
Product
Atropine Sulfate Injection Solution, 0.4 mg/1 mL (0.4 mg/mL), in a) 1 mL syringes and b) 2 mL syringes, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-010-45, UPC: 0100352533010453
Reason for recall
Subpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1153-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.